Professional Bio

Education

  • Pharmacy Practice Residency, Valley Health Systems – Wincester, VA 2009-2010
  • Cardiology Specialty Residency, UMass Memorial Medical Center – Worcester, MA 2010-2011
  • Pharm.D., University of Connecticut, 2009
  • B.S., Pharmaceutical Studies, University of Connecticut, 2007

Professional Memberships

  • American Association of Colleges of Pharmacy
  • American College of Clinical Pharmacy
  • American Pharmacists Association
  • American Society of Health-System Pharmacists

Expertise & Certifications

  • PharmD License, June 2009
  • Advanced Cardiac Life Support (ACLS) Certification, May 2010
  • Basic Life Support (BLS) Certification, October, 2009

Research & Scholarship

Research Interests

Antiplatelet Therapy
Acute Care Cardiology
Anticoagulation

Recent Publications

Nelson, A., Lalama, J. Intermediate-Risk Pulmonary Embolism and Fibrinolysis: For Better or For Worse?. In: Linn WD. eds. Topics in Evidence-Based Pharmacy Practice. New York, NY: McGraw-Hill; 2013. http://accesspharmacy.mhmedical.com.dml.regis.edu/updatesContent.aspx?bookid=533&Sectionid=56747651. Accessed October 06, 2014.

Lalama, J.T., Feeney, M.E., Vandiver JW, Beavers KD, Walter LN, McClintic JR.  Assessing an enoxaparin dosing protocol in morbidly obese patients.  J Thromb Thrombolysis.  2014 [DOI# 10.1007/s11239-014-1117-y].

Khan, S., Lalama, J. "What Is The CHANCE That Dual Antiplatelet Therapy Is Effective for Secondary Stroke Prevention?" (update). In: Linn WD, Al-Qadheeb N, Al-Qadheeb N, Havrda D, eds. Topics in Evidence-Based Pharmacy Practice. New York: McGraw-Hill; 2013. http://www.accesspharmacy.com/content.aspx?aID=4000318. Accessed December 2, 2013.

Feeney, M., Lalama, J. "Can Newer Anticoagulants AMPLIFY the Initial Treatment of VTE?" (update). In: Linn WD, Al-Qadheeb N, Havrda D, Al-Qadheeb N, Havrda D, eds. Topics in Evidence-Based Pharmacy Practice. New York: McGraw-Hill; 2013. http://www.accesspharmacy.com/content.aspx?aID=4000312. Accessed October 27, 2013

Lalama, J. (2013). Can Newer Anticoagulants AMPLIFY the Initial Treatment of VTE? Topics in Evidence-Based Pharmacy PracticeRetrieved from http://accesspharmacy.mhmedical.com/updatesContent.aspx?bookid=533&Sectionid=45242482

Lalama, J. (2012a). Using Aspirin for Primary Prevention of Vascular and Non-Vascular Outcomes: What Are the Data? Topics in Evidence-Based Pharmacy Practice.

Lalama, J. (2012b). Risk of Acute Coronary Events and Dabigatran. Topics in Evidence-Based Pharmacy Practice.

Lalama, J., Lewis, P. M., Gore, J., Tran, M.T. & Donovan, J. (2012). How one academic medical center has managed potency changes with unfractionated heparin. Journal of thrombosis and thrombolysis, 1–5.

Khan, S., Lalama, J. Can A Fish A Day Keep the ED Away?. In: Linn WD. eds.Topics in Evidence-Based Pharmacy PracticeNew York, NY: McGraw-Hill; 2013. http://accesspharmacy.mhmedical.com/updatesContent.aspx?bookid=533&Sectionid=41703424. Accessed April 28, 2014.

Lalama, J. (2012). "Dronedarone: Where To Go from Here?"  In W.D. Linn, N. Al-Qadheeb, D. Havrda, N. Al-Qadheeb, D. Havrda (Eds), Topics in Evidence-Based Pharmacy Practice. http://www.accesspharmacy.com/content.aspx?aID=4000121. AccessPharmacy.

Lalama, J. (2012). "Rivaroxaban: Warfarin's Newest Competitor for Non-Valvular Atrial Fibrillation" (update). In W.D. Linn, N. Al-Qadheeb, D. Havrda, N. Al-Qadheeb, D. Havrda (Eds), Topics in Evidence-Based Pharmacy Practice. http://www.accesspharmacy.com/content.aspx?aID=4000122. AccessPharmacy.

Lalama, J., Brackbill, M. (2011) Characterization and Evaluation of Clopidogrel Response Testing in a Community Hospital Setting. J Clinic Experiment Cardiol 2:155. doi:10.4172/2155-9880.1000155.

Recent Presentations

Martell, C., Lalama, J., Fete, M., Goldwire, M. “Update in the Drug Treatment of Cardiovascular Disease.” Regis University Rueckert-Hartman College for Health Professions, 2nd Annual Summit for Healthcare Professionals; Denver, CO: September 19, 2014

Prasthofer, E., Lalama, J.  Treatment of VTE – review of guidelines and new oral anticoagulants.  Presented at:  Swedish Medical Center Medical Grand Rounds;  Englewood, CO. November 21, 2013.

Todd, B., Hanselin, M., Lalama, J. Clinical pearls: niacin, the old frontier, novel oral drug for cystic fibrosis, preventing clots in the 21st century. 2013 Annual Colorado Pharmacists Society Meeting, Colorado Springs, CO. Platform. May 31, 2013.

Burt, L., Berlau D.J., Buffet L., Hanselin, M., Lalama, J., Sheridan, L., Sucher, B. Overcoming Challenges in TBL: The Regis Approach, Team-Based Learning Collaborative, 11th Annual Team-Based Learning Collaborative, St. Petersburg, FL. March 2, 2012.

Ricchetti, C., Fete, M., Knutsen, S., Lalama, J., Nelson, M., & Wachernah, R. Bringing Classes Together: Developing Integrated, Team-Taught TBL Modules. 2013 Team-Based Learning Collaborative - Annual Meeting. San Diego, CA. March 1, 2013.

McCollum, M., Sucher, A.J., Haight, R., Shea, L., Lalama, J., Martell, C., & Luckey, S. W. PCAT Scores are Predictive of Student Performance in an Integrated Team-Based LearningTM Curriculum. 2012 AACP Annual Meeting. Orlando, FL. 2012.

Lalama, J., Brackbill, M. Utilization of P2Y12 testing and its impact on therapeutic decision making. Presented at the Eastern States Residency Conference. Hershey, PA. April 2010.

Awards & Recognition

  • Teacher of the Year, Regis University School of Pharmacy, P2 class, 2014.
  • Teacher of the Year, Regis University School of Pharmacy, P3 Class, 2012.